Cargando…
Silver and Antibiotic, New Facts to an Old Story
The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163818/ https://www.ncbi.nlm.nih.gov/pubmed/30135366 http://dx.doi.org/10.3390/antibiotics7030079 |
_version_ | 1783359452705980416 |
---|---|
author | Barras, Frédéric Aussel, Laurent Ezraty, Benjamin |
author_facet | Barras, Frédéric Aussel, Laurent Ezraty, Benjamin |
author_sort | Barras, Frédéric |
collection | PubMed |
description | The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics. |
format | Online Article Text |
id | pubmed-6163818 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-61638182018-10-12 Silver and Antibiotic, New Facts to an Old Story Barras, Frédéric Aussel, Laurent Ezraty, Benjamin Antibiotics (Basel) Review The therapeutic arsenal against bacterial infections is rapidly shrinking, as drug resistance spreads and pharmaceutical industry are struggling to produce new antibiotics. In this review we cover the efficacy of silver as an antibacterial agent. In particular we recall experimental evidences pointing to the multiple targets of silver, including DNA, proteins and small molecules, and we review the arguments for and against the hypothesis that silver acts by enhancing oxidative stress. We also review the recent use of silver as an adjuvant for antibiotics. Specifically, we discuss the state of our current understanding on the potentiating action of silver ions on aminoglycoside antibiotics. MDPI 2018-08-22 /pmc/articles/PMC6163818/ /pubmed/30135366 http://dx.doi.org/10.3390/antibiotics7030079 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Barras, Frédéric Aussel, Laurent Ezraty, Benjamin Silver and Antibiotic, New Facts to an Old Story |
title | Silver and Antibiotic, New Facts to an Old Story |
title_full | Silver and Antibiotic, New Facts to an Old Story |
title_fullStr | Silver and Antibiotic, New Facts to an Old Story |
title_full_unstemmed | Silver and Antibiotic, New Facts to an Old Story |
title_short | Silver and Antibiotic, New Facts to an Old Story |
title_sort | silver and antibiotic, new facts to an old story |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6163818/ https://www.ncbi.nlm.nih.gov/pubmed/30135366 http://dx.doi.org/10.3390/antibiotics7030079 |
work_keys_str_mv | AT barrasfrederic silverandantibioticnewfactstoanoldstory AT aussellaurent silverandantibioticnewfactstoanoldstory AT ezratybenjamin silverandantibioticnewfactstoanoldstory |